Biochemical Studies and Assay Development Targeting Novel Anti-cancer Agents

Cancer is a worldwide health problem and is the leading cause of death in Canada; as such, novel treatment strategies are constantly being sought. Compared to normal cells, cancer cells exhibit aberrant metabolism characterized by increased glucose uptake and rapid growth. The development and biochemical analysis of a series of small-molecule drug candidates that possess the ability to selectively disrupt tumour metabolism will lead to a better understanding of cancer cell metabolism as a whole and ultimately, new treatments for cancer. Development of this oncology program will increase the innovative technical capacity of Alectos Therapeutics and expand its capabilities for future drug development programs.

Faculty Supervisor:

Andrew Bennet

Student:

Partner:

Alectos Therapeutics Inc.

Discipline:

Physics

Sector:

University:

Simon Fraser University

Program:

Accelerate